These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 38297486
1. Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps. Low CM, Wang AR, Yong M, Nayak J, Patel Z, Hwang PH. Int Forum Allergy Rhinol; 2024 Jul; 14(7):1249-1252. PubMed ID: 38297486 [Abstract] [Full Text] [Related]
2. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps. Scangas GA, Wu AW, Ting JY, Metson R, Walgama E, Shrime MG, Higgins TS. Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622 [Abstract] [Full Text] [Related]
3. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Dharmarajan H, Falade O, Lee SE, Wang EW. Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344 [Abstract] [Full Text] [Related]
4. Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report. Orlando P, Licci G, Kuitche D, Matucci A, Vultaggio A, Gallo O, Maggiore G. Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1317-1324. PubMed ID: 37910208 [Abstract] [Full Text] [Related]
5. Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps. Parasher AK, Gliksman M, Segarra D, Lin T, Rudmik L, Quast T. Int Forum Allergy Rhinol; 2022 Jun; 12(6):813-820. PubMed ID: 34874120 [Abstract] [Full Text] [Related]
6. Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps. Rimmer J, Fokkens W, Chong LY, Hopkins C. Cochrane Database Syst Rev; 2014 Jun; 2014(12):CD006991. PubMed ID: 25437000 [Abstract] [Full Text] [Related]
7. Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients. De Corso E, Porru DP, Corbò M, Montuori C, De Maio G, Mastrapasqua RF, Panfili M, Spanu C, Di Bella GA, D'Agostino G, Rizzuti A, Passali GC, Galli J. Clin Otolaryngol; 2024 Jul; 49(4):481-489. PubMed ID: 38711363 [Abstract] [Full Text] [Related]
8. The role of revision sinus surgery in the initiation of dupilumab therapy: A real-world study of molecular and cellular features. Gaffar A, Alenezi AR, Kelly KM, Kulaga HM, Keng HT, Smith A, Lane AP. Int Forum Allergy Rhinol; 2024 Oct; 14(10):1647-1651. PubMed ID: 38958596 [Abstract] [Full Text] [Related]
9. Optimizing the timing of biologic and surgical therapy for patients with refractory chronic rhinosinusitis with nasal polyposis (CRSwNP). Garvey E, Naimi B, Duffy A, Hannikainen P, Kahn C, Farquhar D, Rosen M, Rabinowitz M, Toskala E, Nyquist G. Int Forum Allergy Rhinol; 2024 Mar; 14(3):651-659. PubMed ID: 37506043 [Abstract] [Full Text] [Related]
10. Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study. Hoffman V, Mulder K, Topuria I, Gawlicka AK, Kallman JE. Curr Med Res Opin; 2023 Dec; 39(12):1613-1619. PubMed ID: 36994626 [Abstract] [Full Text] [Related]
11. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Bachert C, Hellings PW, Mullol J, Hamilos DL, Gevaert P, Naclerio RM, Joish VN, Chao J, Mannent LP, Amin N, Abbe A, Taniou C, Fan C, Pirozzi G, Graham NMH, Mahajan P, Staudinger H, Khan A. Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495 [Abstract] [Full Text] [Related]
12. Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients. Alicandri-Ciufelli M, Marchioni D, Pipolo C, Garzaro M, Nitro L, Dell'Era V, Ferrella F, Campagnoli M, Russo P, Galloni C, Ghidini A, De Corso E, Lucidi D. Laryngoscope; 2024 Apr; 134(4):1556-1563. PubMed ID: 37632705 [Abstract] [Full Text] [Related]
13. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab. Förster-Ruhrmann U, Szczepek AJ, Bachert C, Olze H. J Allergy Clin Immunol; 2020 Jul; 146(1):218-220.e2. PubMed ID: 32417136 [No Abstract] [Full Text] [Related]
14. Dupilumab improves sleep quality in chronic rhinosinusitis with nasal polyps. Riva G, Garetto M, Borgione M, Piazza F, Prizio C, Dellea D, Albera A, Canale A, Pecorari G. Am J Otolaryngol; 2024 Jul; 45(4):104310. PubMed ID: 38677148 [Abstract] [Full Text] [Related]
15. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Patel GB, Peters AT. Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132 [Abstract] [Full Text] [Related]
16. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP). Hardison SA, Senior BA. J Otolaryngol Head Neck Surg; 2023 Sep 28; 52(1):64. PubMed ID: 37759322 [Abstract] [Full Text] [Related]
17. Cost-utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country. Alvarez L, Querubin J, Bedoya J, Mejia A, Sánchez J. Expert Rev Pharmacoecon Outcomes Res; 2023 Jun 28; 23(5):571-578. PubMed ID: 36976904 [Abstract] [Full Text] [Related]
19. Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis. Boyle JV, Lam K, Han JK. Immunotherapy; 2020 Feb 28; 12(2):111-121. PubMed ID: 32075470 [Abstract] [Full Text] [Related]
20. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis. Aschenbrenner DS. Am J Nurs; 2019 Oct 28; 119(10):21-22. PubMed ID: 31567245 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]